Overview

Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected Patients

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of switching from Retrovir to Tenofovir or Abacavir in HIV-infected patients
Phase:
Phase 4
Details
Lead Sponsor:
Aarhus University Hospital
Treatments:
Abacavir
Dideoxynucleosides
Tenofovir